Citadel Advisors’s OptiNose OPTN Stock Holding History

Citadel Advisors’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-47	Closed	-$1.35K	–	14978
2023 Q1	$1.35K	Sell	47 -840	-95%	-$22.4K	﹤0.01%	14323
2022 Q4	$24.6K	Buy	887 +47	+6%	+$1.78K	﹤0.01%	12957
2022 Q3	$46K	Buy	+840	New	+$46.1K	﹤0.01%	11688
2022 Q2	–	Sell	-667	Closed	-$25K	–	13754
2022 Q1	$25K	Sell	667 -126	-16%	-$4.5K	﹤0.01%	13178
2021 Q4	$19K	Buy	+793	New	+$26.5K	﹤0.01%	13591

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors's OPTN Position: Q3 2024 in Review

Citadel Advisors sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 2,603 shares — an estimated $40.6K sold.

Citadel Advisors first reported a position in OPTN in Q3 2018 and held it in 17 quarters. The position peaked at $1.22M in Q3 2018. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

Citadel Advisors reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
Citadel Advisors sold 2,603 OptiNose shares in Q3 2024, an estimated $40.6K.
Citadel Advisors first reported a position in OptiNose in Q3 2018 and held it in 17 quarters.
Citadel Advisors's OptiNose position peaked at $1.22M in Q3 2018.
65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.